IL2 and ovarian carcinoma: Ex vivo activation of NK cells with cytokines like IL-2, IL-12, IL-15, or IL-18 enhances proliferation, cytokine secretion, and the ability to lyse ovarian cancer cell lines, even those with low MHC-I expression [167,171,172,173,174].